Streetbeat News

Analyst Ratings

DNTH

Oppenheimer has initiated coverage on Dianthus Therapeutics with an Outperform rating and set a price target of $48.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:06 pm

LGND

Oppenheimer has initiated coverage on Ligand Pharmaceuticals with an Outperform rating and set a price target of $135.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:04 pm

AMZN

Amazon.com (NASDAQ:AMZN) has been analyzed by 41 analysts, showing a range of bullish to somewhat bullish sentiments. The average 12-month price target has increased to $226.1. Analysts have adjusted their ratings and price targets, reflecting their views on Amazon's market performance. The company shows strong financial health with impressive revenue growth, net margin, ROE, and ROA, and maintains a balanced debt approach.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 12:02 pm

ALV

Autoliv (NYSE:ALV) has received mixed analyst ratings over the past three months, with a decrease in the average 12-month price target from $129.20 to $121.23. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Autoliv faces challenges in revenue growth and net margin but shows strong ROE and ROA.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 12:02 pm

WOLF

Mizuho analyst Vijay Rakesh has downgraded Wolfspeed (NYSE:WOLF) from Neutral to Underperform and reduced the price target from $17 to $8.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:02 pm

BIGC

Five financial analysts have provided mixed ratings on BigCommerce Holdings (NASDAQ:BIGC) over the past three months, with a current average price target of $11.0, down from $11.60. The company's financial metrics show positive revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 12:02 pm

MEG

Montrose Environmental Group (NYSE:MEG) has received mixed analyst ratings over the past three months, with a majority being bullish. Analysts have set a 12-month price target average of $51.25, a decrease from the previous $54.00. The company shows positive revenue growth but struggles with profitability metrics like ROE and ROA.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 12:00 pm

RIG

Morgan Stanley analyst Daniel Kutz maintains an Equal-Weight rating on Transocean (NYSE:RIG) and raises the price target from $5 to $6.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:00 pm

ASO

Academy Sports (NASDAQ:ASO) has been analyzed by 15 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $60.6, down 3.19% from the previous $62.60. Analysts have adjusted their ratings and price targets, reflecting mixed sentiments. Despite a revenue decline, Academy Sports shows strong profitability and financial performance with a high net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 12:00 pm

ENOV

Enovis (NYSE:ENOV) has been analyzed by four analysts, showing mixed sentiments. The average 12-month price target is $58.75, down from $65.67. Analysts have adjusted their ratings and price targets, reflecting changing market conditions. Enovis, a medical technology company, has shown significant revenue growth and strong financial metrics, despite a negative net margin.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 12:00 pm